<DOC>
	<DOC>NCT01394185</DOC>
	<brief_summary>The number of people seeking treatment for marijuana-related problems is on the rise, yet there is no currently accepted medication proven to help them quit. This research is designed to determine whether the FDA approved medication dronabinol (MarinolÂ®) has effects that might help make it easier for people to stop daily marijuana use, and to carefully study the occurence of safety risks and side-effects at different doses of the drug.</brief_summary>
	<brief_title>Effects of Dronabinol (Oral THC) on Cannabis Use</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Current use of marijuana Able to give informed consent Daily use of psychoactive medication Current Axis I psychiatric disorder other than dependence on cannabis or nicotine, or abuse of drugs or alcohol Women who are pregnant, breast feeding, or planning to become pregnant within the next 3 months Those seeking treatment for cannabisrelated problems or using cannabis under the guidance of a physician for a medical disorder Uncontrolled or unstable cardiovascular disease Allergy to sesame oil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>marijuana</keyword>
	<keyword>dronabinol</keyword>
	<keyword>pharmacotherapy</keyword>
</DOC>